Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome

Kidney International

Volumn 59, Issue 1, 2001, Pages 179-189

  Shearer, Gregory C ^a,b,c   Stevenson, Frazier T ^a,b,c   Atkinson, David N ^a,b,c   Hardin, Jones H ^a,b,c   Staprans, Ilona ^a,b,c   Kaysen, George A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein E; Chylomicron; Proteinuria; Triglyceride; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN E; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; ISOLATED HEART; LIPOPROTEIN METABOLISM; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEINURIA; RAT;

EID: 0035167588     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00478.x     Document Type: Article

References (41)

1. Hyperlipidemia in the nephrotic syndrome
2. The hyperlipidemia of the nephrotic syndrome: Relation to plasma albumin concentration, oncotic pressure, and viscosity
3. Apolipoprotein gene expression in analbuminemic rats and in rats with heymann nephritis
4. Nephrotic hyperlipidemia: Primary abnormalities in both lipoprotein catabolism and synthesis
5. Increased cholesteryl ester transfer activity in plasma from analbuminemic patients
6. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat
7. New aspects on heparin and lipoprotein metabolism
8. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis
9. Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat
10. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma
11. Precautionary measures for collecting blood destined for lipoprotein isolation
12. Sequential flotation ultracentrifugation
13. The role of apolipoprotein processing in receptor recognition of VLDL
14. Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat
15. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats
16. Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata
17. 1-131-labeling of proteins by the iodine monochloride method
18. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: Low doses stimulate hepatic triglyceride production while high doses inhibit clearance
19. Immunochemical analysis by antigen-antibody precipitation in gels
20. Metabolism of cholesterol-rich chylomicrons: Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart
21. Titration of free fatty acids of plasma: A study of current methods and a new modification
22. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis
23. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart
24. Lipoprotein lipase: The molecule and its interactions
25. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis
26. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: Direct evidence that lipoprotein lipase bridging occurs in vivo
27. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein e-triglyceriderich lipoprotein particles: A major pathway at physiological particle concentrations
28. Mechanism of hypertriglyceridemia in Dahl salt-sensitive rats, an animal model of spontaneous nephrotic syndrome
29. Catabolism of very low density lipoproteins in experimental nephrosis
30. Gene expression of lipoprotein lipase in experimental nephrosis
31. Lipoprotein lipase in clinical and experimental nephrosis
32. Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis
33. Post-prandial lipoprotein metabolism in nephrotic syndrome
34. Down-regulation of hepatic lipase expression in experimental nephrotic syndrome
35. Acquired VLDL receptor deficiency in experimental nephrosis
36. LDL receptor family-dependent and -independent pathways for the internalization and digestion of lipoprotein lipase-associated beta-VLDL by rat vascular smooth muscle cells
37. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: Structural and kinetic study
38. Molecular basis of exchangeable apolipoprotein function
39. Apolipoprotein e mediates uptake of sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts
40. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome
41. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: Overproduction of triglyceride-rich lipoprotein is not an obligatory factor